Gonadoblastoma: Immunohistochemical localization of Mullerian- inhibiting substance, inhibin, WT-1, and p53

Modern Pathology

Volumn 10, Issue 11, 1997, Pages 1101-1105

  Hussong, J ^a   Crussi, F G ^b   Chou, P M ^b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Gonadoblastoma; Inhibin; Mullerian inhibiting substance; p53; Sex cord stromal tumors; Tumor suppressor gene; WT1

Indexed keywords

INHIBIN; MUELLERIAN INHIBITING FACTOR; PROTEIN P53;

ADOLESCENT; ARTICLE; CASE REPORT; FEMALE; GENE EXPRESSION; GERM CELL TUMOR; GONADOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEX CORD TUMOR; TUMOR SUPPRESSOR GENE;

ADOLESCENT; DNA-BINDING PROTEINS; FEMALE; GENES, WILMS TUMOR; GLYCOPROTEINS; GONADOBLASTOMA; GROWTH INHIBITORS; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBINS; MULLERIAN DUCTS; OVARIAN NEOPLASMS; TESTICULAR HORMONES; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; WT1 PROTEINS;

EID: 0030726468     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Scully RE. Gonadoblastoma: a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer 1950;6:455-63.
2. Robboy SJ, Miller T, Donahoe PK, Jahre C, Welch WR, Haseltine FP, et al. Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis; perspective derived from a clinicopathologic analysis of 21 cases. Hum Pathol 1982;13:700-16.
3. Nordqvist K. Sex differentiation: gonadogenesis and novel genes. Int J Dev Biol 1995;39:727-36.
4. Ying S-Y. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988;9:267-93.
5. Matzuk M, Finegold MJ, Su J-G J, Hseueh AJW, Bradley A. α inhibin is a tumor suppressor gene with a gonadal specificity in mice. Nature 1993;360:313-9.
6. Scully RE. Gonadoblastoma. A review of 74 cases. Cancer 1970;25:1340-56.
7. Jorgensen N, Muller J, Jaubert F, Clausen OP, Skakkebaek NE. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia, and testicular carcinoma in situ cells. Histopathology 1997;30:177-86.
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
9. Bartlova J, Bartek J, Lucas J, Vojesek B, Staskova Z, Rejthar A, et al. p53 protein alterations in human testicular cancer including preinvasive intratubular germ-cell neoplasia. Int J Cancer 1991;49:196-202.
10. Kuczyk MA, Serth J, Bokemeyer C, Allhoff EP, Jonassen J, Kuczyk S, et al. Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. Pathol Res Pract 1994;190: 993-8.
11. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, et al. The candidate Wilms' tumor gene is involved in genitourinary development. Nature 1990; 346:194-7.
12. Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 1991;5:1345-56.
13. Almon E, Goldfinger N, Kapon A, Schwartz D, Levine AJ, Rotter V. Testicular tissue-specific expression of the p53 suppressor gene. Dev Biol 1993;156:107-116.
14. Battifora H. p53 immunohistochemistry: a word of caution. Hum Pathol 1994;25:435-6.
15. Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry? Revisited. J Pathol 1994;172:1-4.
16. Jost A. Recherches sur la differenciation sexuelle de l'embryon de lapin. Arch Anat Microsc Morphol Exp 1947; 36:271-315.
17. Josso N, Cate RL, Picard J-Y, Vigier B, di Clemente N, Wilson C, et al. Anti-Müllerian hormone: the Jost factor. Recent Prog Horm Res 1993;48:1-59.
18. Picon R. Action du testicule foetal sur le development in vitro des canaux de Müller chez le rat. Arch Anat Micros Morphol Exp 1969;58:1-19.
19. Cate RL, Donahoe PK, MacLaughlin DT. Müllerian inhibiting substance. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. Vol. 2. Berlin, Germany: Springer-Verlag; 1990. pp 179-210.
20. McLaren A. Development of the mammalian gonad: the fate of the supporting cell lineage. Bioessays 1991;13:151-6.
21. Talerman A. A mixed germ cell-sex cord stroma tumor in a normal female infant. Obstet Gynecol 1972;40:473-8.
22. Costa MJ, DeRose PB, Roth LM, Brescia RJ, Zaloudek CJ, Cohen C. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value. Hum Pathol 1994;25:60-6.
23. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, deBruijn HW. Inhibin as a marker for granulosa-cell tumors. N Engl J Med 1989;321:790-3.
24. Cooke I, O'Brien M, Charnock FM, Groome N, Ganesan TS. Inhibin as a marker of ovarian cancer. Br J Cancer 1995;71: 1046-50.
25. Henderson KM, Franchimont P. Regulation of inhibin production by bovine ovarian cells in vitro. J Reprod Fertility 1981;63:431-42.